CONTROVERSY ON THE MANAGEMENT OF ANTICOAGULANTS AND ANTIPLATELET AGENTS FOR SCHEDULED ENDOSCOPY

被引：5

作者：

Ono, Satoshi ^{[2
]}

Fujishiro, Mitsuhiro ^{[1
]}

Kodashima, Shinya

Minatsuki, Chihiro ^{[2
]}

Hirano, Kosuke ^{[2
]}

Niimi, Keiko ^{[2
]}

Goto, Osamu ^{[2
]}

Yamamichi, Nobutake ^{[2
]}

Koike, Kazuhiko ^{[2
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Endoscopy & Endoscop Surg, Bunkyo Ku, Tokyo 1138655, Japan

[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan

来源：

DIGESTIVE ENDOSCOPY | 2011年 / 23卷 / 01期

关键词：

anticoagulant; antiplatelet agent; cessation; endoscopy; complication; THERAPY; RISK; ASPIRIN; CLOPIDOGREL; STROKE;

D O I：

10.1111/j.1443-1661.2010.01042.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Guidelines on the management of anticoagulants and antiplatelet agents for endoscopy were established by Japan Gastroenterological Endoscopy Society (JGES) in 2005. However, the permeation of the JGES guideline is reported to possibly be low. One of the important causes of this problem is the confusing situation of gaps between the guidelines of various societies. Additionally, our ongoing investigation has revealed another important cause, which is the current daily clinical practice that cessation periods before endoscopy were determined by non-gastroenterological specialists who might be unfamiliar with the JGES guidelines. Considering the low permeation of the guidelines for non-gastroenterological specialists prescribing these agents, we propose that close coordination between various specialists is mandatory to fill the gap between endoscopists and non-gastroenterological specialists.

引用

页码：1 / 4

页数：4

共 50 条

[41] Prevention of GI bleeding due to antiplatelet agents: a labyrinth!
Bretagne, Jean-Francois
PRESSE MEDICALE, 2009, 38 (12): : 1722 - 1726
[42] The perioperative management of antiplatelet agents for chronic subdural hematoma
Mizutani, Katsuhiro
Miwa, Tomoru
Tamura, Ryota
Tomita, Hideyuki
CLINICAL NEUROLOGY AND NEUROSURGERY, 2014, 117 : 100 - 101
[43] Antiplatelet agents in acute cerebral ischaemia: Limits and opportunities
Leys, Didier
Deplanque, Dominique
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (07): : 935 - 945
[44] Management of anticoagulation and antiplatelet agents in the radical cystectomy patient
Smelser, Woodson W.
Jones, Charles P.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 691 - 697
[45] Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs
Pannach, Sven
Goetze, Julia
Marten, Sandra
Schreier, Thomas
Tittl, Luise
Beyer-Westendorf, Jan
JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) : 1211 - 1220
[46] Antiplatelet agents and diabetes mellitus
Drouet, L.
Sollier, C. Bal Dit
Henry, P.
ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2010, 59 : S104 - S112
[47] The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury
Peck, Kimberly A.
Calvo, Richard Y.
Schechter, Mark S.
Sise, C. Beth
Kahl, Jessica E.
Shackford, Meghan C.
Shackford, Steven R.
Sise, Michael J.
Blaskiewicz, Donald J.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 76 (02): : 431 - 436
[48] Therapy strategies for acute coronary syndrome and after coronary interventions. Antiplatelet agents and anticoagulants
Divchev, D.
Nienaber, C.
Ince, H.
INTERNIST, 2011, 52 (11): : 1292 - 1300
[49] Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
Levi, M.
Eerenberg, E.
Kamphuisen, P. W.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (09) : 1705 - 1712
[50] Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan E.D.
Sacco R.L.
Current Neurology and Neuroscience Reports, 2002, 2 (1) : 31 - 37

← 1 2 3 4 5 →